ATE445012T1 - Mit rheumatischer arthritis assoziierte spleissvariante von cd44 - Google Patents
Mit rheumatischer arthritis assoziierte spleissvariante von cd44Info
- Publication number
- ATE445012T1 ATE445012T1 AT00935449T AT00935449T ATE445012T1 AT E445012 T1 ATE445012 T1 AT E445012T1 AT 00935449 T AT00935449 T AT 00935449T AT 00935449 T AT00935449 T AT 00935449T AT E445012 T1 ATE445012 T1 AT E445012T1
- Authority
- AT
- Austria
- Prior art keywords
- transcript
- found
- exon
- novel
- variant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70585—CD44
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2884—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD44
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Detergent Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL13035699A IL130356A0 (en) | 1999-06-08 | 1999-06-08 | Novel CD44 variant |
| IL13364799A IL133647A0 (en) | 1999-06-08 | 1999-12-21 | Novel cd44 variant |
| PCT/IL2000/000326 WO2000075312A1 (en) | 1999-06-08 | 2000-06-07 | Cd44 splice variant associated with rheumatoid arthritis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE445012T1 true ATE445012T1 (de) | 2009-10-15 |
Family
ID=26323849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00935449T ATE445012T1 (de) | 1999-06-08 | 2000-06-07 | Mit rheumatischer arthritis assoziierte spleissvariante von cd44 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20030108984A1 (de) |
| EP (1) | EP1187917B1 (de) |
| AT (1) | ATE445012T1 (de) |
| AU (1) | AU5098800A (de) |
| DE (1) | DE60043104D1 (de) |
| IL (1) | IL133647A0 (de) |
| WO (1) | WO2000075312A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7534605B2 (en) * | 1999-06-08 | 2009-05-19 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases |
| CA2441206A1 (en) | 2001-03-19 | 2002-09-26 | Gyros Ab | Characterization of reaction variables |
| AU2002326112A1 (en) * | 2001-08-09 | 2003-02-24 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Cd44 variants carrying heparan sulfate chains and uses thereof |
| DE60316106T2 (de) * | 2002-01-09 | 2008-05-29 | Faron Pharmaceuticals Oy | Gemeinsamer lymphatischer endothel- und gefässendothel-rezeptor-1 (clever-1) und seine verwendung |
| ATE533788T1 (de) * | 2003-07-15 | 2011-12-15 | Yissum Res Dev Co | Antikörper gegen cd44vra und methoden zu ihrer verwendung |
| JP4459179B2 (ja) * | 2005-03-30 | 2010-04-28 | 株式会社東芝 | 情報処理装置及びその方法 |
| US20060294607A1 (en) * | 2006-03-29 | 2006-12-28 | Applera Corporation | Human podocalyxin alternative-spliced forms and uses thereof |
| WO2009007934A2 (en) * | 2007-07-10 | 2009-01-15 | Neurim Pharmaceuticals (1991) Ltd. | Cd44 splice variants in neurodegenerative diseases |
| WO2010058396A1 (en) * | 2008-11-19 | 2010-05-27 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | A cd44vra antibody and diagnostic and therapeutic methods using same |
| HUE049261T2 (hu) | 2014-07-15 | 2020-09-28 | Yissum Research And Development Company Of The Hebrew Univ Of Jerusalem Ltd | CD44 izolált polipeptidek és alkalmazásaik |
| WO2024093147A1 (zh) * | 2022-10-31 | 2024-05-10 | 南京元迈细胞生物科技有限公司 | 一种特异性结合CD44的v5外显子的抗体及其用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| USH735H (en) * | 1988-03-30 | 1990-02-06 | The United States Of America As Represented By The United States Department Of Energy | Lead-203 as a label for radioimaging |
| AU5543594A (en) * | 1992-10-30 | 1994-05-24 | Duke University | An adhesion molecule |
| CA2164728A1 (en) * | 1993-06-22 | 1995-01-05 | Helmut Ponta | Processes for diagnosing and analysing tumours |
| DE19708713C2 (de) * | 1997-03-04 | 2002-11-28 | Boehringer Ingelheim Int | Verwendung von anti-CD44 Antikörpern enthaltenden Präparationen zur Behandlung bestimmter Tumore und zur Unterdrückung von Immunreaktionen |
| ATE533788T1 (de) * | 2003-07-15 | 2011-12-15 | Yissum Res Dev Co | Antikörper gegen cd44vra und methoden zu ihrer verwendung |
-
1999
- 1999-12-21 IL IL13364799A patent/IL133647A0/xx unknown
-
2000
- 2000-06-07 EP EP00935449A patent/EP1187917B1/de not_active Expired - Lifetime
- 2000-06-07 AU AU50988/00A patent/AU5098800A/en not_active Abandoned
- 2000-06-07 WO PCT/IL2000/000326 patent/WO2000075312A1/en not_active Ceased
- 2000-06-07 DE DE60043104T patent/DE60043104D1/de not_active Expired - Lifetime
- 2000-06-07 AT AT00935449T patent/ATE445012T1/de not_active IP Right Cessation
-
2001
- 2001-12-07 US US10/012,969 patent/US20030108984A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000075312A1 (en) | 2000-12-14 |
| EP1187917A1 (de) | 2002-03-20 |
| IL133647A0 (en) | 2001-04-30 |
| EP1187917B1 (de) | 2009-10-07 |
| DE60043104D1 (de) | 2009-11-19 |
| US20030108984A1 (en) | 2003-06-12 |
| AU5098800A (en) | 2000-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Asl et al. | A novel apolipoprotein A-1 variant, Arg173Pro, associated with cardiac and cutaneous amyloidosis | |
| Baba et al. | A novel allelic variant of serum amyloic A, SAA1γ: genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA–amyloidosis | |
| DE60043104D1 (de) | Mit rheumatischer arthritis assoziierte spleissvariante von cd44 | |
| EP0753580A3 (de) | Zellspezifische Gentherapie mit Hilfe eines neuen Promotors für den "Tissue Inhibitor of Metalloproteinase-3" | |
| ATE435281T1 (de) | Im cadasil bezogenes gen, diagnostikums-verfahren und therapeutische verwendung | |
| DE60037800D1 (de) | Stereoselektive antifibrillogene peptide | |
| DE69728864D1 (de) | Direkte molekulare diagnose von friedreich ataxia | |
| ATE389724T1 (de) | Menschliche dnase i hyperaktive varianten | |
| WO2004045553A3 (en) | Ca125 gene and its use for diagnostic and therapeutic interventions | |
| ATE221125T1 (de) | Klonierte glutaminsäure-decarboxylase | |
| IL141021A (en) | Use of copolymer-like polypeptide-1 to prepare a drug to treat autoimmune diseases | |
| DK1295944T3 (da) | GDP-dissociationsstimulerende protein, hjernespecifikt nukleosomsamlingsprotein, skeletmuskelspecifikt ubiquitinkonjugerende enzym, celleproliferationsprotein, phosphatidylinositolkinase, nelbeslægtede proteiner | |
| BR9607336A (pt) | Composições de aminoácidos e utilidades das mesmas em nutrição clinica | |
| IS2819B (is) | Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra | |
| DE69735020D1 (de) | Verfahren zur Diagnose von Prostatakrebs | |
| WO1997044454A3 (en) | Human phospholipase inhibitor | |
| Peterson et al. | Increased spectrin proteolysis in fibroblasts from aged and Alzheimer donors | |
| NO993653D0 (no) | Fremgangsmåte for diagnose, prognose og behandling av glaukom og relaterte sykdommer | |
| Paepe et al. | Homozygosity by descent for a COL1A2 mutation in two sibs with severe osteogenesis imperfecta and mild clinical expression in the heterozygotes | |
| US20040018188A9 (en) | Sparc-related proteins | |
| Park et al. | Cloning of the genes encoding mouse cardiac and skeletal calsequestrins: expression pattern during embryogenesis | |
| BR9808625A (pt) | O uso de proteìnas extraìveis de órgãos de animal para a preparação de medicamentos para o tratamento de condições patológicas caracterizadas por hiperprodução de fator de necrose de tumor (tnf) | |
| Lund et al. | Cloning and sequencing of the bovine gastrin gene | |
| Nuytinck et al. | Osteogenesis imperfecta phenotypes resulting from serine for glycine substitutions in the α2 (I) collagen chain | |
| ATE218064T1 (de) | Immunogene tlp-zusammensetzung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |